Mutual of America Capital Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.99M | Buy |
175,627
+10,808
| +7% | +$307K | 0.05% | 441 |
|
|
2025
Q1 | $4.87M | Buy |
164,819
+305
| +0.2% | +$9K | 0.06% | 434 |
|
|
2024
Q4 | $4.78M | Sell |
164,514
-483
| -0.3% | -$14K | 0.05% | 464 |
|
|
2024
Q3 | $7.58M | Sell |
164,997
-19,252
| -10% | -$884K | 0.08% | 274 |
|
|
2024
Q2 | $7.53M | Buy |
184,249
+40,913
| +29% | +$1.67M | 0.08% | 257 |
|
|
2024
Q1 | $3.66M | Sell |
143,336
-5,866
| -4% | -$150K | 0.04% | 634 |
|
|
2023
Q4 | $1.35M | Buy |
149,202
+15,245
| +11% | +$138K | 0.02% | 1010 |
|
|
2023
Q3 | $855K | Buy |
133,957
+3,323
| +3% | +$21.2K | 0.01% | 1050 |
|
|
2023
Q2 | $1.45M | Buy |
+130,634
| New | +$1.45M | 0.02% | 996 |
|